1.
Increased 3-Hydroxykynurenine serum concentrations differentiate Alzheimer’s disease patients from controls
by Schwarz, Markus J
European archives of psychiatry and clinical neuroscience, 2012-11-29, Vol.263 (4), p.345-352
2.
Biomarkers for Antidepressant Efficacy of Electroconvulsive Therapy: An Exploratory Cerebrospinal Fluid Study
by Kranaster, Laura
Neuropsychobiology, 2018-11, Vol.77 (1), p.13-22
3.
A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: Schizophrenia and major depression as inflammatory CNS disorders
by Müller, Norbert
European archives of psychiatry and clinical neuroscience, 2008-05-31, Vol.258 (Suppl 2), p.97-106
4.
Inflammatory processes and schizophrenia: two independent lines of evidence from a study of twins discordant and concordant for schizophrenic disorders
by Braun, Silke
European archives of psychiatry and clinical neuroscience, 2017-04-04, Vol.267 (5), p.377-389
5.
Correction to: Actovegin® reduces PMA‑induced inflammation on human cells
by Reichl, Franz-Xaver
European journal of applied physiology, 2021-10-15, Vol.122 (1), p.267-267
6.
Actovegin® reduces PMA-induced inflammation on human cells
by Reichl, Franz-Xaver
European journal of applied physiology, 2020-05-23, Vol.120 (7), p.1671-1680
7.
Kynurenine pathway and white matter microstructure in bipolar disorder
by Poletti, Sara
European archives of psychiatry and clinical neuroscience, 2016-09-12, Vol.268 (2), p.157-168
8.
Prenatal immunologic predictors of postpartum depressive symptoms: a prospective study for potential diagnostic markers
by Krause, Daniela
European archives of psychiatry and clinical neuroscience, 2014-10, Vol.264 (7), p.615-24
9.
COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy
by Müller, Norbert
European archives of psychiatry and clinical neuroscience, 2004-02, Vol.254 (1), p.14-22
10.
Neuroimmune-endocrine crosstalk in schizophrenia and mood disorders
by Müller, Norbert
Expert review of neurotherapeutics, 2006-07-01, Vol.6 (7), p.1017-1038
11.
Clinical effects of COX-2 inhibitors on cognition in schizophrenia
by Müller, Norbert
European archives of psychiatry and clinical neuroscience, 2005-04, Vol.255 (2), p.149-151
12.
Intracellular monocytic cytokine levels in schizophrenia show an alteration of IL-6
by Krause, Daniela L
European archives of psychiatry and clinical neuroscience, 2012-01-21, Vol.262 (5), p.393-401
13.
S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin Resistance
by Steiner, Johann
Cardiovascular Psychiatry and Neurology, 2010-05-10, Vol.2010, p.480707-11
14.
IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia
by Schwarz, Markus J
European archives of psychiatry and clinical neuroscience, 2006-03, Vol.256 (2), p.72-76
15.
Deficiency of GDP-Man:GlcNAc2-PP-Dolichol mannosyltransferase causes congenital disorder of glycosylation type iK
by SCHWARZ, Markus
American journal of human genetics, 2004, Vol.74 (3), p.472-481
16.
The bisphosphonate ibandronate accelerates osseointegration of hydroxyapatite-coated cementless implants in an animal model
by Eberhardt, Christian
Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2007-01, Vol.12 (1), p.61-66
17.
The role of immune function in schizophrenia: an overview
by Müller, N
European archives of psychiatry and clinical neuroscience, 1999, Vol.249 Suppl 4 (S4), p.62-S68
18.
Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms
by Riedel, Michael
European archives of psychiatry and clinical neuroscience, 2005-12, Vol.255 (6), p.432-437
19.
High dosage treatment of nitrogen-containing bisphosphonate ibandronate is required for osseointegration of cementless metal implants
by Eberhardt, Christian
Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2005-11, Vol.10 (6), p.622-626
20.
Correction to: Actovegin® reduces PMAâinduced inflammation on human cells
by Reichl, Franz-Xaver
European journal of applied physiology, 2022-01-01, Vol.122 (1), p.267
